Pituitary action of cytokines: Focus on BMP-4 and gp130 family
The anterior pituitary can develop benign tumors of different sizes, classified as micro- and macroadenomas, frequently associated with high levels of hormone production, leading to different associated syndromes like Cushing's disease, acromegaly or prolactinomas. Much work has been done in or...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2007
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 16788caa a22015977a 4500 | ||
|---|---|---|---|
| 001 | PAPER-6613 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203618.0 | ||
| 008 | 190411s2007 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-34248175283 | |
| 024 | 7 | |2 cas |a retinoic acid, 302-79-4; Bone Morphogenetic Proteins; Cytokine Receptor gp130, 133483-10-0; Cytokines; bone morphogenetic protein 4 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a NUNDA | ||
| 100 | 1 | |a Giacomini, D. | |
| 245 | 1 | 0 | |a Pituitary action of cytokines: Focus on BMP-4 and gp130 family |
| 260 | |c 2007 | ||
| 270 | 1 | 0 | |m Arzt, E.; Laboratorio de Fisiología Y Biología Molecular, Departamento de Fisiología Y Biología Molecular Y Celular, Pabellón II, C1428EHA, Buenos Aires, Argentina; email: earzt@fbmc.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumours (2002) Nat Rev Cancer, 2, pp. 836-849 | ||
| 504 | |a Kovacs, K., Horvath, E., Vidal, S., Classification of pituitary adenomas (2001) J Neurooncol, 54, pp. 121-127 | ||
| 504 | |a Yu, R., Melmed, S., Oncogene activation in pituitary tumors (2001) Brain Pathol, 11, pp. 328-341 | ||
| 504 | |a Arzt, E., Pereda, M.P., Castro, C.P., Pagotto, U., Renner, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Front Neuroendocrinol, 20, pp. 71-95 | ||
| 504 | |a Arzt, E., gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuroendocrine pathways (2001) J Clin Invest, 108, pp. 1729-1733 | ||
| 504 | |a Hirano, T., Interleukin-6 (1994) The Cytokine Handbook, pp. 145-168. , Thomson AW ed, ed 2. Osaka, Academic Press | ||
| 504 | |a Kishimoto, T., Taga, T., Akira, S., Cytokine signal transduction (1994) Cell, 76, pp. 253-262 | ||
| 504 | |a Kishimoto, T., Akira, S., Narazaki, M., Taga, T., Interleukin-6 family of cytokines and gp130 (1995) Blood, 86, pp. 1243-1254 | ||
| 504 | |a Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway (1998) Biochem J, 334, pp. 297-314 | ||
| 504 | |a Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Kishimoto, T., Targeted disruption of gp130, a common signal transducer for the interleukin-6 family, leads to myocardial and hematological disorders (1996) Proc Natl Acad Sci USA, 93, pp. 407-411 | ||
| 504 | |a Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., Akira, S., Targeted disruption of the mouse Stat3 gene leads to early embryonic lathality (1997) Proc Natl Acad Sci USA, 94, pp. 3801-3804 | ||
| 504 | |a Rodig, S.J., Meraz, M.A., White, J.M., Lampe, P.A., Riley, J.K., Arthur, C.D., Kind, K.L., Schreiber, R.D., Disruption of the JaK1 gene demonstrates obligatory and nonredundant roles of the JaKs in cytokine-induced biologic responses (1998) Cell, 93, pp. 373-383 | ||
| 504 | |a Betz, U.A., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Muller, W., Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects (1998) J Exp Med, 188, pp. 1955-1965 | ||
| 504 | |a Massague, J., How cells read TGF-β signals (2000) Nat Rev Mol Cell Biol, 1, pp. 169-178 | ||
| 504 | |a Massague, J., TGF-β signal transduction (1998) Annu Rev Biochem, 67, pp. 753-791 | ||
| 504 | |a Shi, Y., Massague, J., Mechanisms of TGF-β signaling from cell membrane to the nucleus (2003) Cell, 113, pp. 685-700 | ||
| 504 | |a Spangelo, B.L., MacLeod, R.M., Isakson, P.C., Production of interleukin-6 by anterior pituitary cells in vitro (1990) Endocrinology, 126, pp. 582-586 | ||
| 504 | |a Vankelecom, H., Carmeliet, P., Van Damme, J., Billiau, A., Denef, C., Production of interleukin-6 by folliculostellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system (1989) Neuroendocrinology, 49, pp. 102-106 | ||
| 504 | |a Ray, D., Melmed, S., Pituitary cytokine and growth factor expression and action (1997) Endocr Rev, 18, pp. 206-228 | ||
| 504 | |a Arzt, E., Páez Pereda, M., Costas, M., Sauer, J., Renner, U., Holsboer, F., Stalla, G.K., Cytokine expression and molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth (1998) Ann NY Acad Sci, 840, pp. 525-531 | ||
| 504 | |a Renner, U., Gloddek, J., Páez Pereda, M., Arzt, E., Stalla, G.K., Regulation and role of intrapituitary IL-6 production by folliculostellate cells (1998) Domest Anim Endocrinol, 15, pp. 353-362 | ||
| 504 | |a Arzt, E., Páez Pereda, M., Perez Castro, C., Kovalovsky, D., Nagashima, A.C., Renner, U., Stalla, G.K., Cytokines and pituitary function (1999) Regulation in Pituitary Hormone Secretion, pp. 15-26. , Beck-Peccoz P ed, BioScientifica Ltd. Bristol, UK | ||
| 504 | |a Spangelo, B.L., Gorospe, W.C., Role of the cytokines in the neuroendocrine-immune system axis (1995) Front Neuroendocrinol, 16, pp. 1-12 | ||
| 504 | |a Páez Pereda, M., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Chervín, A., Arzt, E., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Exp Clin Endocrinol Diabetes, 108, pp. 202-207 | ||
| 504 | |a Scully, K.M., Rosenfeld, M.G., Pituitary development: Regulatory codes in mammalian organogenesis (2002) Science, 295, pp. 2231-2235 | ||
| 504 | |a Treier, M., Gleiberman, A.S., O'Connell, S.M., Szeto, D.P., McMahon, J.A., McMahon, A.P., Rosenfeld, M.G., Multistep signaling requirements for pituitary organogenesis in vivo (1998) Genes Dev, 12, pp. 1691-1704 | ||
| 504 | |a Drouin, J., Molecular mechanisms of pituitary differentiation and regulation: Implications for hormone deficiencies and hormone resistance syndromes (2006) Front Horm Res, 35, pp. 74-87 | ||
| 504 | |a Dasen, J.S., Rosenfeld, M.G., Signaling and transcriptional mechanisms in pituitary development (2001) Annu Rev Neurosci, 24, pp. 327-355 | ||
| 504 | |a Ericson, J., Norlin, S., Jessell, T.M., Edlund, T., Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary (1998) Development, 125, pp. 1005-1015 | ||
| 504 | |a Watkins-Chow, D.E., Camper, S.A., How many homeobox genes does it take to make a pituitary gland? (1998) Trends Genet, 14, pp. 284-290 | ||
| 504 | |a Páez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Arzt, E., Involvement of bone morphogenetic protein-4 in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proc Natl Acad Sci USA, 100, pp. 1034-1039 | ||
| 504 | |a Giacomini, D., Páez-Pereda, M., Theodoropoulou, M., Labeur, M., Refojo, D., Gerez, J., Chervin, A., Arzt, E., Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action (2006) Endocrinology, 147, pp. 247-256 | ||
| 504 | |a Takeda, M., Otsuka, F., Suzuki, J., Kishida, M., Ogura, T., Tamiya, T., Makino, H., Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas (2003) Biochem Biophys Res Commun, 306, pp. 812-818 | ||
| 504 | |a Lyson, K., McCann, S.M., The effect of interleukin-6 on pituitary hormone release in vivo and in vitro (1991) Neuroendocrinology, 54, pp. 262-266 | ||
| 504 | |a Arzt, E., Buric, R., Stelzer, G., Stalla, J., Sauer, J., Renner, U., Stalla, G.K., Interleukin (IL) involvement in anterior pituitary cell growth regulation: Effects of IL-2 and IL-6 (1993) Endocrinology, 132, pp. 459-467 | ||
| 504 | |a Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells (1997) Exp Clin Endocrinol Diabetes, 105, pp. 345-352 | ||
| 504 | |a Sawada, T., Koike, K., Kanda, Y., Ikegami, H., Jikihara, T., Maeda, T., Osako, Y., Miyake, A., Interleukin-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vitro (1995) J Endocrinol Invest, 18, pp. 83-90 | ||
| 504 | |a Páez Pereda, M., Goldberg, V., Chervin, A., Carrizo, G., Molina, A., Andrada, J., Sauer, J., Arzt, E., Interleukin (IL)-2 and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants (1996) Mol Cell Endocrinol, 124, pp. 33-42 | ||
| 504 | |a Perez Castro, C., Nagashima, A.C., Pereda, M.P., Goldberg, V., Chervin, A., Largen, P., Renner, U., Arzt, E., The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines (2000) Endocrinology, 141, pp. 1746-1753 | ||
| 504 | |a Nudi, M., Ouimette, J.F., Drouin, J., Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity (2005) Mol Endocrinol, 19, pp. 1329-1342 | ||
| 504 | |a Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, G., Retinoic acid prevents experimental Cushing syndrome (2001) J Clin Invest, 108, pp. 1123-1131 | ||
| 504 | |a Castillo, V., Giacomini, D., Páez-Pereda, M., Stalla, J., Labeur, M., Theodoropoulou, M., Holsboer, F., Arzt, E., Retinoic acid as a novel medical therapy for Cushing's disease in dogs (2006) Endocrinology, 147, pp. 4438-4444 | ||
| 504 | |a Horiguchi, A., Oya, M., Marumo, K., Murai, M., STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P (2002) Kidney Int, 61, pp. 926-938 | ||
| 504 | |a Liu, X.H., Kirschenbaum, A., Lu, M., Yao, S., Klausner, A., Preston, C., Holland, J.F., Levine, A.C., Prostaglandin E2 stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway (2002) Biochem Biophys Res Commun, 290, pp. 249-255 | ||
| 504 | |a Campbell, C.L., Jiang, Z., Savarese, D.M., Savarese, T.M., Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma (2001) Am J Pathol, 158, pp. 25-32 | ||
| 504 | |a Burger, R., Guenther, A., Bakker, F., Schmalzing, M., Bernand, S., Baum, W., Duerr, B., Gramatzki, M., gp130 and ras mediated signaling in human plasma cell line INA-6: A cytokine-regulated tumor model for plasmacytoma (2001) Hematol J, 2, pp. 42-53 | ||
| 504 | |a Leung, C.K.H., Shiu, P.C., Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice (1981) Cancer Res, 41, pp. 546-551 | ||
| 504 | |a Yano, T., Uozumi, T., Kawamoto, K., Mukada, K., Onda, J., Ito, A., Fujimoto, N., Photodynamic therapy for rat pituitary tumor in vitro and in vivo using pheophorbide-a and white light (1991) Lasers Surg Med, 11, pp. 174-182 | ||
| 504 | |a Davalli, A.M., Galbiati, F., Bertuzzi, F., Polastri, L., Pontiroli, A.E., Perego, L., Freschi, M., Meoni, C., Insulin-secreting pituitary GH3 cells: A potential β-cell surrogate for diabetes cell therapy (2000) Cell Transplant, 9, pp. 841-851 | ||
| 504 | |a Castro, C.P., Giacomini, D., Nagashima, A.C., Onofri, C., Graciarena, M., Kobayashi, K., Páez-Pereda, M., Arzt, E., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144, pp. 693-700 | ||
| 504 | |a Tone, E., Kunisawa, K., Kumanogoh, A., Negoro, S., Funamoto, M., Osugi, T., Kishimoto, T., Yamauchi-Takihara, K., gp130-dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation (2000) Cytokine, 12, pp. 1512-1518 | ||
| 504 | |a Koyama, C., Matsumoto, H., Sakai, T., Wakabayashi, K., Ito, A., Couch, E.F., Inoue, K., Pituitary folliculo-stellate-like cells stimulate somatotropic pituitary tumor growth in nude mice (1995) Endocr Pathol, 6, pp. 67-75 | ||
| 504 | |a Graciarena, M., Carbia-Nagashima, A., Onofri, C., Perez-Castro, C., Giacomini, D., Renner, U., Stalla, G.K., Arzt, E., Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model (2004) Eur J Endocrinol, 151, pp. 595-604 | ||
| 520 | 3 | |a The anterior pituitary can develop benign tumors of different sizes, classified as micro- and macroadenomas, frequently associated with high levels of hormone production, leading to different associated syndromes like Cushing's disease, acromegaly or prolactinomas. Much work has been done in order to understand the signaling pathways and the factors and hormones involved in the pituitary tumorigenic process. In recent years, much evidence has been collected and it is now well documented that cytokines of the gp130 family, such as interleukin-6, that use gp130 as a common signaling protein stimulate not only the proliferation but also the hormone secretion of pituitary cells. Experiments in vivo have shown that the overexpression of the gp130 receptor resulted in pituitary abnormal growth. Moreover, it has been recently described that bone morphogenetic protein-4 (BMP-4), a member of the TGF-β family, has a stimulatory role on lactosomatotropic cells promoting the development of prolactinomas but it has an inhibitory action on the corticotropic lineage. This inhibitory action prevents Cushing's disease progression. Furthermore, BMP-4 mediates the antiproliferative action of retinoic acid in these cells. The present review highlights the most recent work about gp130 and TGF-β cytokine families and their role in pituitary tumorigenesis. Copyright © 2007 S. Karger AG. |l eng | |
| 593 | |a Laboratorio de Fisiología Y Biología Molecular, Departamento de Fisiología Y Biología Molecular Y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a Max Planck Institute of Psychiatry, Munich, Germany | ||
| 593 | |a Affectis Pharmaceuticals, Munich, Germany | ||
| 593 | |a Laboratorio de Fisiología Y Biología Molecular, Departamento de Fisiología Y Biología Molecular Y Celular, Pabellón II, C1428EHA, Buenos Aires, Argentina | ||
| 593 | |a IFYBINE-Argentine National Research Council (CONICET), Argentina | ||
| 690 | 1 | 0 | |a GP130 FAMILY |
| 690 | 1 | 0 | |a PITUITARY ACTION OF CYTOKINES |
| 690 | 1 | 0 | |a TGF-Β FAMILY |
| 690 | 1 | 0 | |a BONE MORPHOGENETIC PROTEIN 4 |
| 690 | 1 | 0 | |a CYTOKINE |
| 690 | 1 | 0 | |a GLYCOPROTEIN GP 130 |
| 690 | 1 | 0 | |a INTERLEUKIN 6 |
| 690 | 1 | 0 | |a RETINOIC ACID |
| 690 | 1 | 0 | |a ACROMEGALY |
| 690 | 1 | 0 | |a ADENOHYPOPHYSIS |
| 690 | 1 | 0 | |a ADENOHYPOPHYSIS DISEASE |
| 690 | 1 | 0 | |a BENIGN TUMOR |
| 690 | 1 | 0 | |a CARCINOGENESIS |
| 690 | 1 | 0 | |a CELL PROLIFERATION |
| 690 | 1 | 0 | |a CONFERENCE PAPER |
| 690 | 1 | 0 | |a CUSHING DISEASE |
| 690 | 1 | 0 | |a DISEASE ASSOCIATION |
| 690 | 1 | 0 | |a DISEASE COURSE |
| 690 | 1 | 0 | |a GENE OVEREXPRESSION |
| 690 | 1 | 0 | |a HORMONE RELEASE |
| 690 | 1 | 0 | |a HORMONE SYNTHESIS |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HYPOPHYSIS CELL |
| 690 | 1 | 0 | |a HYPOPHYSIS TUMOR |
| 690 | 1 | 0 | |a IN VIVO STUDY |
| 690 | 1 | 0 | |a MICROADENOMA |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROLACTINOMA |
| 690 | 1 | 0 | |a PROTEIN FAMILY |
| 690 | 1 | 0 | |a SIGNAL TRANSDUCTION |
| 690 | 1 | 0 | |a TUMOR CLASSIFICATION |
| 690 | 1 | 0 | |a TUMOR VOLUME |
| 690 | 1 | 0 | |a ANIMALS |
| 690 | 1 | 0 | |a BONE MORPHOGENETIC PROTEINS |
| 690 | 1 | 0 | |a CYTOKINE RECEPTOR GP130 |
| 690 | 1 | 0 | |a CYTOKINES |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a MODELS, BIOLOGICAL |
| 690 | 1 | 0 | |a MULTIGENE FAMILY |
| 690 | 1 | 0 | |a PITUITARY GLAND |
| 700 | 1 | |a Acuña, M. | |
| 700 | 1 | |a Gerez, J. | |
| 700 | 1 | |a Nagashima, A.C. | |
| 700 | 1 | |a Silberstein, S. | |
| 700 | 1 | |a Páez-Pereda, M. | |
| 700 | 1 | |a Labeur, M. | |
| 700 | 1 | |a Theodoropoulou, M. | |
| 700 | 1 | |a Renner, U. | |
| 700 | 1 | |a Stalla, G.K. | |
| 700 | 1 | |a Arzt, E. | |
| 773 | 0 | |d 2007 |g v. 85 |h pp. 94-100 |k n. 2 |p Neuroendocrinology |x 00283835 |w (AR-BaUEN)CENRE-6253 |t Neuroendocrinology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-34248175283&doi=10.1159%2f000100428&partnerID=40&md5=bbbf9ed542fc2ece9869ffa7bca3f4a5 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000100428 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00283835_v85_n2_p94_Giacomini |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00283835_v85_n2_p94_Giacomini |y Registro en la Biblioteca Digital |
| 961 | |a paper_00283835_v85_n2_p94_Giacomini |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 67566 | ||